Le Vu, Stéphane
241  Ergebnisse:
Personensuche X
?
3

Characteristics associated with the residual risk of severe..:

Semenzato, Laura ; Botton, Jérémie ; Drouin, Jérôme...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.lanepe.2022.100441.  , 2022
 
?
6

Characteristics associated with the residual risk of severe..:

Semenzato, Laura ; Botton, Jérémie ; Drouin, Jérôme...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.lanepe.2022.100441.  , 2022
 
?
7

Characteristics associated with the residual risk of severe..:

Semenzato, Laura ; Botton, Jérémie ; Drouin, Jérôme...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.lanepe.2022.100441.  , 2022
 
?
8

Characteristics associated with the residual risk of severe..:

Semenzato, Laura ; Botton, Jérémie ; Drouin, Jérôme...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.lanepe.2022.100441.  , 2022
 
?
10

Prevalence of SARS-CoV-2 antibodies in France: results from..:

Vu, Stéphane Le ; Jones, Gabrielle ; Anna, François...
info:eu-repo/semantics/altIdentifier/doi/10.1101/2020.10.20.20213116.  , 2021
 
?
11

Patterns of antibiotic use in hospital-acquired infections:

SEVIN, Thibaud ; Daniau, Come ; Alfandari, Serge...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jhin.2021.05.008.  , 2021
 
?
12

COVID-19 hotspots through clusters analysis in France (may–..:

Spaccaferri, Guillaume ; Calba, Clémentine ; Vilain, Pascal...
info:eu-repo/semantics/altIdentifier/doi/10.1186/s12889-021-11857-8.  , 2021
 
?
14

Prevalence of SARS-CoV-2 antibodies in France: results from..:

Vu, Stéphane Le ; Jones, Gabrielle ; Anna, François...
info:eu-repo/semantics/altIdentifier/doi/10.1101/2020.10.20.20213116.  , 2021
 
1-15